Mutations in CIC and FUBP1 contribute to human oligodendroglioma
about
The spectrum of SWI/SNF mutations, ubiquitous in human cancersNCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomesIntegrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastomaRecent advances in the molecular understanding of glioblastomaIn vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studiesOligodendroglioma: pathology, molecular mechanisms and markersEGFR/Ras Signaling Controls Drosophila Intestinal Stem Cell Proliferation via Capicua-Regulated GenesComprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.The epidemiology of glioma in adults: a "state of the science" reviewATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarizationDetection of circulating tumor DNA in early- and late-stage human malignanciesRecursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumorsPhase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial.Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomasThe genetic landscape of anaplastic astrocytoma.Molecular Testing of Brain Tumor.Integrated analysis of recurrent properties of cancer genes to identify novel driversGlioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and scienceATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples.The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA.Quantitative iTRAQ LC-MS/MS Proteomics Reveals Transcription Factor Crosstalk and Regulatory Networks in Hypopharyngeal Squamous Cell CarcinomaTargetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.Genetic landscape of extreme responders with anaplastic oligodendroglioma.Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascadeImaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapiesDistinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.FBP1 Is an Interacting Partner of Menin.Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.Medical therapy of gliomas.Cancer genomics and pathology: all together now.Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.Discovery of structural alterations in solid tumor oligodendroglioma by single molecule analysis.Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicitySNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas.TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.A mathematical model for short-term vs. long-term survival in patients with glioma.
P2860
Q21090801-A351AB20-A85F-4D0B-BD89-9717903453D9Q24596715-5BBCFE52-4927-4CC2-A883-47B744867780Q24630017-C4BB7FC2-74CE-4493-B178-15550F0B9FCDQ24632928-9F223DC9-C417-4D0D-A936-01FF48EB1C43Q26820289-2E933776-D6B1-4961-BC25-37820D819E6BQ27002448-83015BC2-72CA-4FE6-A372-E7BC21F0FED2Q27310105-5C608EC0-AE45-41FF-B9C9-B3BF845315E5Q27853175-0BC3244E-316D-43DE-8956-AFF7091EC4F9Q28387839-EFE14266-FDFC-47E3-B8BF-FF7A44A2906CQ28593691-2A9E7E15-4921-4266-A469-B32A86823D14Q29615778-3F56219E-E76F-441C-9A05-3E87177C041CQ30370204-D0BDF9A0-BDD4-4512-A62C-B33DEA01F3FBQ30542081-DDFF545B-6903-4777-86D0-D1ECEAC49138Q30836702-29CB0817-C5DB-49F6-8F90-DBC247F21F8EQ33554186-4B23A4A3-34F8-439D-9763-763A3D48F3BAQ33688888-12983646-E73F-40FB-9893-6A88188F3851Q33729693-E5638E1D-A206-4D3B-94B1-5F920BE97CCDQ33742981-0DEFD169-8A01-4399-A230-51F4A21B58EBQ33746514-EFBF5371-00DB-4CDD-B0AF-33247DB0786DQ33757037-FE26B362-D8AD-4B74-8396-73AE3CFAD144Q33792857-F76F87BA-AD02-45F1-B683-DABE3B463E64Q33794367-8FC70B52-3E5F-47E9-B3EA-4972CFAC2157Q33804713-51B3273E-B4E7-44F6-AF21-604063FF3CC2Q33829209-E089121E-BB6F-4215-815E-5111A64CEEFDQ33835854-7C9887C0-5888-44B9-8FE7-86F51DC25AC5Q33894486-0F025650-5F55-4DA5-81CF-2436EDD0735BQ33925544-E295D240-485A-4854-8701-6C7AAC1DAA53Q33938943-26A7B074-B015-46FB-B778-7299E7212513Q34009803-1A2AEEB9-2649-44BC-BA33-190CA529BD6CQ34091425-A07F4AAA-0C6C-4482-A105-816AB0D1FEF2Q34218761-618F89D6-0480-4D66-8858-E21E1DAACE43Q34301519-868EACA0-2074-4FB7-926E-7819F9795B07Q34332857-87C02D1B-E198-410B-8AA4-6C9457127F54Q34359802-03D3E54F-4872-4804-8319-0384BB6620CDQ34362617-300A4758-8BBD-4557-97E7-5FB6414358A9Q34365966-F54D5696-DEDA-4D51-9B6B-D949870D5275Q34446905-A837373B-CB31-41C1-9843-FD210EA919FDQ34499685-87636900-4A04-4833-8126-CF768C239FBAQ34635517-D37995A6-657B-4B72-89E1-153D60680DA5Q34704964-2654BEA5-34C7-420C-BECC-100A2579A481
P2860
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
@ast
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
@en
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
@nl
type
label
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
@ast
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
@en
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
@nl
prefLabel
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
@ast
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
@en
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
@en
P2093
Chetan Bettegowda
Fausto J Rodriguez
Gregory Riggins
Laura D Wood
Mark Sausen
Nickolas Papadopoulos
Nishant Agrawal
Sueli Mieko Oba-Shinjo
Suely Kazue Nagahashi Marie
P2860
P304
P3181
P356
10.1126/SCIENCE.1210557
P407
P50
P577
2011-09-09T00:00:00Z